Miller, Anne http://orcid.org/0000-0002-5587-7497
York, Elisa M. http://orcid.org/0000-0001-8479-5231
Stopka, Sylwia A. http://orcid.org/0000-0003-3761-6899
Martínez-François, Juan Ramón http://orcid.org/0000-0002-1035-2574
Hossain, Md Amin http://orcid.org/0000-0001-7136-503X
Baquer, Gerard http://orcid.org/0000-0002-4433-4972
Regan, Michael S. http://orcid.org/0000-0001-5252-2829
Agar, Nathalie Y. R. http://orcid.org/0000-0003-3149-3146
Yellen, Gary http://orcid.org/0000-0003-4228-7866
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS102586, R01 NS126248, R01 NS126248, R01 NS102586)
Harvard Medical School: Dean’s Innovation Award Harvard Medical School: Lefler Small Grant Award
European Molecular Biology Organization (ALTF 589-2020)
Harvard Medical School: Alice and Joseph Brooks Fund Postdoctoral Fellowship
Harvard Medical School: Hearst Fellowship
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (T32 EB025823)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA210180)
Massachusetts Life Sciences Center
Article History
Received: 15 November 2022
Accepted: 9 August 2023
First Online: 5 October 2023
Competing interests
: N.Y.R.A. is a key opinion leader to Bruker. The other authors declare no competing interests.